Drug details

Ontak (denileukin diftitox)

type of Interleukin Inhibitors

Ontak (denileukin diftitox) is a is a recombinant DNA-derived cytotoxic protein that works by killing certain blood/cancer cells from the immune system (e.g., B cells, T cells), used to treat leukemia and lymphomas, including cutaneous (of the skin) T-cell lymphoma.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• shortness of breath,
• dizziness,
• rapid weight gain,
• chest pain
• little or no urine,
• sudden swelling,
• irregular heartbeats, and

The following drugs are related to Ontak, either as a replacement or used together:

• Truxima (rituximab-abbs injection)
• Ukoniq (umbralisib tablets)

The following supplements are related to Ontak, and may be used together with the drug:

• Melatonin (s.)
• Adenosine (s.)
• Coriolus Mushroom (s.)